Key Takeaways Labcorp highlighted new peer-reviewed data showing Plasma Detect's MRD tracking capabilities. Two studies demonstrated its value in monitoring early progression and detecting residual cancer. Findings suggest LH's Plasma Detect may guide treatment decisions across multiple cancer settings. Labcorp (LH) recently announced that the Labcorp Plasma Detect was featured in two recent peer-reviewed publications – Nature Medicine and Clinical Cancer Research. Labcorp Plasma Detect is a tumor-informed, ...